Chronic Lymphocytic Leukemia Responds to Dermal Chelation
Chronic Lymphocytic Leukemia Responds to Dermal Chelation
The purpose of this clinical trial is to identify 50 participants with Chronic Lymphocytic
 Leukemia (CLL) and follow their total white blood cell (WBC) counts and absolute lymphocyte
 counts after performing dermal chelation and administering nutritional therapy
The purpose of this clinical trial is to use dermal chelation and hair tissue analysis to
 identify 50 participants with CLL. The total wbc counts and absolute lymphocyte counts of
 these participants will be followed after serial dermal chelations and nutritional therapy.
Inclusion Criteria:

 -  Clinical diagnosis of Chronic Lymphocytic Leukemia and has a toxic heavy metal load

 -  Toxic heavy metal load

 Exclusion Criteria:

 -  Pregnant

 -  Pacemaker implants

 -  Organ transplant recipients

 -  Psychotic episodes or epileptic seizures